We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Sysmex Demonstrates Hematology, Urinalysis and Flow Cytometry Solutions at AACC 2022

By LabMedica International staff writers
Posted on 25 Jul 2022

Sysmex America, Inc. More...

(Lincolnshire, IL, USA) is exhibiting virtually and live at the 73rd AACC Annual Scientific Meeting & Clinical Lab Expo, July 24-28, where the company will be presenting its extensive portfolio of innovative products and automation solutions that help transform healthcare.

At the Sysmex America booth, the company is featuring the XN-Series of automated hematology analyzers with new complimentary products, including the XN-9100 automated hematology analyzer which is a scalable, modular automation system that offers efficiencies to meet the needs of varying lab sizes, specialties and complexity levels. With automated workload balancing, hands-free rerun/reflex testing and fully automated reflexive slide preparation, labs can better manage workload and staffing challenges. The DI-60 Automated Digital Cell Morphology Analyzer connects directly to the XN-9100 analyzer or can be configured with the SP-50 Slidemaker/Stainer. Also, on display for the first time will be the BT-50 Barcode Terminal and Start yard with “touch-free” quality control (QC) workflow. For labs with confined space, the TA-01 Automated Tube Archiver and the TS-01 Automated Tube Sorter provide increased automation in a smaller footprint.

For physicians’ offices and clinics, Sysmex America is showcasing the XN-L automated hematology analyzer series with BeyondCare Quality Monitor (BCQM) that has been designed to simplify operation, daily maintenance, QC and calibration. With a low-WBC application, the XN-L improves the reliability of analysis. In addition, the XN-L provides a six-part differential (including IG # enumeration and IG %) for each sample. For low-volume hematology labs, the company will be highlighting the CellaVision DC-1 analyzer which automates and simplifies performing blood cell differentials while providing labs with high-quality digital imaging for improved efficiency, quality, connectivity and staff proficiency. Laboratories with space limitations may use the CellaVision DC-1 as a standalone or networked installation.

In the field of urinalysis, Sysmex America is exhibiting the UN-Series automated urinalysis solution with expanded chemistry functionality. The fully scalable UN-Series automated urinalysis solution offers the world’s first bi-directional urinalysis connection for Total Lab Automation (TLA). Connecting the UN-Series to Inpeco’s FlexLab automation system enables a solution tailored to your individual workflow needs and eliminates manual touch-points with urine samples. The UN-Series offers a full spectrum of urinalysis screening parameters with a throughput of up to 240 samples/hour. The UN-Series offers modular instrument configurations for flexibility in managing a wide range of workflow needs for growing labs. In addition, customizable reflex rules ensure further urinalysis workflow enhancement and greater levels of automation.

In the area of flow cytometry, Sysmex America is showcasing the highly automated XF-1600 Flow Cytometer which provides laboratories with improved flexibility and efficiency for a wide range of applications. In addition to seamless integration into the laboratory’s workflow, the XF-1600 works in tandem with Sysmex America’s PS-10 Sample Preparation System to automate the entire process of antibody staining, incubation and flow cytometry analysis - ensuring a new level of confidence in the results produced. Sysmex America is also displaying the highly automated and flexible PS-10 sample preparation system that is designed for complex laboratory-developed tests and routine flow cytometry applications, and provides clinical laboratories with a new level of workflow efficiency and confidence in accurate results.

“An estimated 3.3 billion in vitro diagnostic tests are run every year in the United States to detect the presence or risk of certain diseases,” said Andy Hay, chief executive officer of Sysmex America. “As the testing demand continues to grow with factors such as aging of the population and increases in chronic and infectious disease, laboratories across North America will continue to rely on Sysmex America for highly automated solutions that provide workflow efficiency levels to meet shorter turnaround times with accuracy.”
 

Related Links:
Sysmex America, Inc. 


Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The liquid biopsy approach measures randomness in DNA methylation patterns to detect early-stage cancer signals in blood (Photo courtesy of 123RF)

Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability

Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.